A novel RSV vaccine candidate derived from anti-idiotypic antibodies targets putative neutralizing B-cells in bulk PBMCs
Scharffenberger, S., McGuire, A.T.To be published.
Experimental Data Snapshot
Starting Models: experimental
View more details
wwPDB Validation   3D Report Full Report
Entity ID: 1 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| 2C1 Light Chain | A [auth B] | 214 | Homo sapiens | Mutation(s): 0  | ![]() |
Entity Groups   | |||||
| Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
Sequence AnnotationsExpand | |||||
| |||||
Entity ID: 2 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| 2C1 Heavy Chain | B [auth A] | 238 | Homo sapiens | Mutation(s): 0  | ![]() |
Entity Groups   | |||||
| Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
Sequence AnnotationsExpand | |||||
| |||||
Entity ID: 3 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| ADI-19425 Heavy Chain | C [auth H] | 227 | Homo sapiens | Mutation(s): 0  | ![]() |
Entity Groups   | |||||
| Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
Sequence AnnotationsExpand | |||||
| |||||
Entity ID: 4 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| ADI-19425 Light Chain | D [auth L] | 218 | Homo sapiens | Mutation(s): 0  | ![]() |
Entity Groups   | |||||
| Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
Sequence AnnotationsExpand | |||||
| |||||
| Ligands 2 Unique | |||||
|---|---|---|---|---|---|
| ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
| SO4 Query on SO4 | H [auth B], I [auth B] | SULFATE ION O4 S QAOWNCQODCNURD-UHFFFAOYSA-L | |||
| EDO Query on EDO | E [auth B], F [auth B], G [auth B], J [auth A], K [auth A] | 1,2-ETHANEDIOL C2 H6 O2 LYCAIKOWRPUZTN-UHFFFAOYSA-N | |||
| Modified Residues 1 Unique | |||||
|---|---|---|---|---|---|
| ID | Chains | Type | Formula | 2D Diagram | Parent |
| PCA Query on PCA | B [auth A] | L-PEPTIDE LINKING | C5 H7 N O3 | GLN | |
| Length ( Å ) | Angle ( ˚ ) |
|---|---|
| a = 66.802 | α = 90 |
| b = 66.93 | β = 103.74 |
| c = 130.191 | γ = 90 |
| Software Name | Purpose |
|---|---|
| PHENIX | refinement |
| PHENIX | phasing |
| HKL-3000 | data reduction |
| HKL-3000 | data scaling |
| Funding Organization | Location | Grant Number |
|---|---|---|
| National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID) | United States | R21AI156063 |